10x Genomics Inc (TXG)
26.57
-0.95
(-3.45%)
USD |
NASDAQ |
Apr 25, 11:38
10x Genomics Total Assets (Quarterly): 965.14M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 965.14M |
September 30, 2023 | 948.54M |
June 30, 2023 | 989.64M |
March 31, 2023 | 1.014B |
December 31, 2022 | 1.029B |
September 30, 2022 | 996.21M |
June 30, 2022 | 1.002B |
March 31, 2022 | 1.003B |
December 31, 2021 | 1.019B |
September 30, 2021 | 990.57M |
Date | Value |
---|---|
June 30, 2021 | 977.58M |
March 31, 2021 | 954.03M |
December 31, 2020 | 929.34M |
September 30, 2020 | 1.043B |
June 30, 2020 | 582.80M |
March 31, 2020 | 610.38M |
December 31, 2019 | 605.92M |
September 30, 2019 | 572.82M |
June 30, 2019 | 155.59M |
December 31, 2018 | 124.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
155.59M
Minimum
Jun 2019
1.043B
Maximum
Sep 2020
862.52M
Average
977.58M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
Teladoc Health Inc | 4.392B |
American Shared Hospital Services | 48.16M |
Novo Integrated Sciences Inc | 34.95M |
Astrana Health Inc | 933.36M |
Cryo-Cell International Inc | 61.71M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 224.10M |
Shareholders Equity (Quarterly) | 741.04M |
Current Ratio | 4.687 |